As of Feb 27
| -0.34 / -2.56%|
The 3 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 25.00, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +93.50% increase from the last price of 12.92.
The current consensus among 3 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.